1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 PTCA Balloon 1.2.3 PTCA Guide 1.3 Market by Application 1.3.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals and Clinics 1.3.3 Ambulatory Surgical Centers 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Perspective (2017-2028) 2.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Growth Trends by Region 2.2.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Historic Market Size by Region (2017-2022) 2.2.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Forecasted Market Size by Region (2023-2028) 2.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Dynamics 2.3.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Industry Trends 2.3.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Drivers 2.3.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Challenges 2.3.4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Players by Revenue 3.1.1 Global Top Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Players by Revenue (2017-2022) 3.1.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue Market Share by Players (2017-2022) 3.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue 3.4 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Concentration Ratio 3.4.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue in 2021 3.5 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Key Players Head office and Area Served 3.6 Key Players Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Product Solution and Service 3.7 Date of Enter into Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Breakdown Data by Type 4.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Historic Market Size by Type (2017-2022) 4.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Forecasted Market Size by Type (2023-2028) 5 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Breakdown Data by Application 5.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Historic Market Size by Application (2017-2022) 5.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (2017-2028) 6.2 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2017-2022) 6.3 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (2017-2028) 7.2 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2017-2022) 7.3 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (2017-2028) 8.2 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2017-2022) 8.3 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (2017-2028) 9.2 Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2017-2022) 9.3 Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (2017-2028) 10.2 Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2017-2022) 10.3 Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Boston Scientific 11.1.1 Boston Scientific Company Detail 11.1.2 Boston Scientific Business Overview 11.1.3 Boston Scientific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction 11.1.4 Boston Scientific Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) 11.1.5 Boston Scientific Recent Development 11.2 Abbott 11.2.1 Abbott Company Detail 11.2.2 Abbott Business Overview 11.2.3 Abbott Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction 11.2.4 Abbott Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) 11.2.5 Abbott Recent Development 11.3 Medtronic 11.3.1 Medtronic Company Detail 11.3.2 Medtronic Business Overview 11.3.3 Medtronic Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction 11.3.4 Medtronic Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) 11.3.5 Medtronic Recent Development 11.4 Cardinal Health 11.4.1 Cardinal Health Company Detail 11.4.2 Cardinal Health Business Overview 11.4.3 Cardinal Health Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction 11.4.4 Cardinal Health Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) 11.4.5 Cardinal Health Recent Development 11.5 Asahi Intecc 11.5.1 Asahi Intecc Company Detail 11.5.2 Asahi Intecc Business Overview 11.5.3 Asahi Intecc Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction 11.5.4 Asahi Intecc Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) 11.5.5 Asahi Intecc Recent Development 11.6 Terumo 11.6.1 Terumo Company Detail 11.6.2 Terumo Business Overview 11.6.3 Terumo Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction 11.6.4 Terumo Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) 11.6.5 Terumo Recent Development 11.7 MicroPort 11.7.1 MicroPort Company Detail 11.7.2 MicroPort Business Overview 11.7.3 MicroPort Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction 11.7.4 MicroPort Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) 11.7.5 MicroPort Recent Development 11.8 Lepu Medical 11.8.1 Lepu Medical Company Detail 11.8.2 Lepu Medical Business Overview 11.8.3 Lepu Medical Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction 11.8.4 Lepu Medical Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) 11.8.5 Lepu Medical Recent Development 11.9 Biosensors International 11.9.1 Biosensors International Company Detail 11.9.2 Biosensors International Business Overview 11.9.3 Biosensors International Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction 11.9.4 Biosensors International Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) 11.9.5 Biosensors International Recent Development 11.10 Philips 11.10.1 Philips Company Detail 11.10.2 Philips Business Overview 11.10.3 Philips Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction 11.10.4 Philips Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) 11.10.5 Philips Recent Development 11.11 Yinyi 11.11.1 Yinyi Company Detail 11.11.2 Yinyi Business Overview 11.11.3 Yinyi Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction 11.11.4 Yinyi Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) 11.11.5 Yinyi Recent Development 11.12 Wellinq 11.12.1 Wellinq Company Detail 11.12.2 Wellinq Business Overview 11.12.3 Wellinq Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction 11.12.4 Wellinq Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) 11.12.5 Wellinq Recent Development 11.13 Teleflex 11.13.1 Teleflex Company Detail 11.13.2 Teleflex Business Overview 11.13.3 Teleflex Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction 11.13.4 Teleflex Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) 11.13.5 Teleflex Recent Development 11.14 Sinomed 11.14.1 Sinomed Company Detail 11.14.2 Sinomed Business Overview 11.14.3 Sinomed Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction 11.14.4 Sinomed Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) 11.14.5 Sinomed Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of PTCA Balloon Table 3. Key Players of PTCA Guide Table 4. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Region (2017-2022) Table 8. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Region (2023-2028) Table 10. Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Trends Table 11. Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Drivers Table 12. Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Challenges Table 13. Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Restraints Table 14. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Players (2017-2022) Table 16. Global Top Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products as of 2021) Table 17. Ranking of Global Top Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Product Solution and Service Table 21. Date of Enter into Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue Market Share by Type (2017-2022) Table 25. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue Market Share by Type (2023-2028) Table 27. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue Market Share by Application (2017-2022) Table 29. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue Market Share by Application (2023-2028) Table 31. North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2023-2028) & (US$ Million) Table 41. Boston Scientific Company Detail Table 42. Boston Scientific Business Overview Table 43. Boston Scientific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Product Table 44. Boston Scientific Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) & (US$ Million) Table 45. Boston Scientific Recent Development Table 46. Abbott Company Detail Table 47. Abbott Business Overview Table 48. Abbott Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Product Table 49. Abbott Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) & (US$ Million) Table 50. Abbott Recent Development Table 51. Medtronic Company Detail Table 52. Medtronic Business Overview Table 53. Medtronic Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Product Table 54. Medtronic Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) & (US$ Million) Table 55. Medtronic Recent Development Table 56. Cardinal Health Company Detail Table 57. Cardinal Health Business Overview Table 58. Cardinal Health Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Product Table 59. Cardinal Health Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) & (US$ Million) Table 60. Cardinal Health Recent Development Table 61. Asahi Intecc Company Detail Table 62. Asahi Intecc Business Overview Table 63. Asahi Intecc Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Product Table 64. Asahi Intecc Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) & (US$ Million) Table 65. Asahi Intecc Recent Development Table 66. Terumo Company Detail Table 67. Terumo Business Overview Table 68. Terumo Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Product Table 69. Terumo Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) & (US$ Million) Table 70. Terumo Recent Development Table 71. MicroPort Company Detail Table 72. MicroPort Business Overview Table 73. MicroPort Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Product Table 74. MicroPort Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) & (US$ Million) Table 75. MicroPort Recent Development Table 76. Lepu Medical Company Detail Table 77. Lepu Medical Business Overview Table 78. Lepu Medical Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Product Table 79. Lepu Medical Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) & (US$ Million) Table 80. Lepu Medical Recent Development Table 81. Biosensors International Company Detail Table 82. Biosensors International Business Overview Table 83. Biosensors International Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Product Table 84. Biosensors International Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) & (US$ Million) Table 85. Biosensors International Recent Development Table 86. Philips Company Detail Table 87. Philips Business Overview Table 88. Philips Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Product Table 89. Philips Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) & (US$ Million) Table 90. Philips Recent Development Table 91. Yinyi Company Detail Table 92. Yinyi Business Overview Table 93. Yinyi Percutaneous Transluminal Coronary Angioplasty (PTCA) ProductsProduct Table 94. Yinyi Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) & (US$ Million) Table 95. Yinyi Recent Development Table 96. Wellinq Company Detail Table 97. Wellinq Business Overview Table 98. Wellinq Percutaneous Transluminal Coronary Angioplasty (PTCA) ProductsProduct Table 99. Wellinq Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) & (US$ Million) Table 100. Wellinq Recent Development Table 101. Teleflex Company Detail Table 102. Teleflex Business Overview Table 103. Teleflex Percutaneous Transluminal Coronary Angioplasty (PTCA) ProductsProduct Table 104. Teleflex Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) & (US$ Million) Table 105. Teleflex Recent Development Table 106. Sinomed Company Detail Table 107. Sinomed Business Overview Table 108. Sinomed Percutaneous Transluminal Coronary Angioplasty (PTCA) ProductsProduct Table 109. Sinomed Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) & (US$ Million) Table 110. Sinomed Recent Development Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Type: 2021 VS 2028 Figure 2. PTCA Balloon Features Figure 3. PTCA Guide Features Figure 4. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Application in 2021 & 2028 Figure 5. Hospitals and Clinics Case Studies Figure 6. Ambulatory Surgical Centers Case Studies Figure 7. Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Report Years Considered Figure 8. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 9. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Region: 2021 VS 2028 Figure 11. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Players in 2021 Figure 12. Global Top Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products as of 2021) Figure 13. The Top 10 and 5 Players Market Share by Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue in 2021 Figure 14. North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 15. North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Country (2017-2028) Figure 16. United States Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. Canada Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Country (2017-2028) Figure 20. Germany Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. France Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. U.K. Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Italy Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Russia Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Nordic Countries Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Region (2017-2028) Figure 28. China Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Japan Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. South Korea Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Southeast Asia Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. India Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Australia Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Country (2017-2028) Figure 36. Mexico Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Brazil Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Country (2017-2028) Figure 40. Turkey Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Saudi Arabia Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Boston Scientific Revenue Growth Rate in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) Figure 43. Abbott Revenue Growth Rate in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) Figure 44. Medtronic Revenue Growth Rate in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) Figure 45. Cardinal Health Revenue Growth Rate in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) Figure 46. Asahi Intecc Revenue Growth Rate in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) Figure 47. Terumo Revenue Growth Rate in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) Figure 48. MicroPort Revenue Growth Rate in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) Figure 49. Lepu Medical Revenue Growth Rate in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) Figure 50. Biosensors International Revenue Growth Rate in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) Figure 51. Philips Revenue Growth Rate in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) Figure 52. Yinyi Revenue Growth Rate in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) Figure 53. Wellinq Revenue Growth Rate in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) Figure 54. Teleflex Revenue Growth Rate in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) Figure 55. Sinomed Revenue Growth Rate in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022) Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Boston Scientific Abbott Medtronic Cardinal Health Asahi Intecc Terumo MicroPort Lepu Medical Biosensors International Philips Yinyi Wellinq Teleflex Sinomed